Financial Statements

Sanofi (SNY)

$52.9

+0.34 (+0.65%)
Income Statement
Balance Sheet
Cash Flow

Income Statement

All numbers are in thousands

Retained Earning Schedule

Year 2021 2020 2019 2018 2017
Retained Earnings (Previous Year) -----
Net Income 6,22312,3142,8064,3068,434
Stock Dividends -2,215-8,3771,028-533-4,724
Dividend Paid -4,008-3,937-3,834-3,773-3,710
Retained Earnings -----

PPE Schedule

Year 2021 2020 2019 2018 2017
Gross PPE 10,56311,0179,6519,579-
Annual Depreciation 3,4561,6603,1822,04911,535
Capital Expenditure -2,043-2,114-1,816-1,977-1,956
Net PPE 11,97610,56311,0179,6519,579

Intangible and Goodwill Schedule

Year 2021 2020 2019 2018 2017
Intangible and Goodwill (Previous Year) -40,26444,23544,51944,364
New Purchases -161-137-38-137-311
Intangible and Goodwill 40,26444,23544,51944,364-

Sanofi income statement is the only one that provides an overview of company sales and net income
The reasoning behind the adjustment, however, is that free cash flow is meant to measure money being spent right now, not transactions that happened in the past. This makes Sanofi FCF a useful instrument for identifying growing companies with high up-front costs, which may eat into earnings now but have the potential to pay off later.